www.bestgenerics.net
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Lamivudine - Combivir, Epivir
Generic Combivir
Lamivudine - Zidovudine 150mg + 300mg
Generic Combivir is in a group of medicines called reverse transcriptase inhibitors. It is used for treating HIV infection in combination with other medicines.
$1.44
Buy now!
Generic Epivir
Generic Epivir is used for treating HIV infection in combination with other medicines.
$1.73
Buy now!
Choose Your language:
- Testimonials
-
Just to inform you that your package was received Friday 27 th October 14 days after dispatch , excellent service , no problems with customs , also thank you for free extra tablets , you can if you wish use this letter as a recommendation for your company , many thanks
Read more »
-
- Aurobindo Pharma receives final approval for Lamivudine+Zidovudine Tablets - Equity Bulls
- Moneycontrol
- Lupin Launches Generic Combivir Tablets - RTT News
- Moneycontrol
- Lupin, Aurobindo get USFDA nod for HIV drug - Economic Times
- Lupin, Aurobindo get USFDA nod for HIV drugEconomic TimesLupin Pharmaceuticals Inc, a subsidiary of Lupin Ltd, has received final approval from US Food and Drug Administration (USFDA) for its generic Lamivudine and Zidovudine combination tablet in strength of 150mg/300 mg, Lupin said in a statement
- LANDMARK HIV DRUG'S PATENT EXPIRES TODAY - U-T San Diego
- LANDMARK HIV DRUG'S PATENT EXPIRES TODAYU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS
- New Advances in Chronic Hepatitis B - Medscape
- New Advances in Chronic Hepatitis BMedscapeTenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
 |
Subscribe to the News |
|---|
